-
Diagnostics World | Funding for PCR-based in-home medical diagnostics, microcarriers for cell-based assays, higher-order protein structural analysis, 3D genomics, AI-powered single-cell analysis, and more.
Mar 31, 2022
-
Diagnostics World News | A genomic network model is used to identify aurora kinase inhibitor-sensitive lung tumors, AI seeks to improved prostate cancer diagnosis and prognosis, improved liver cancer detection is achieved with simple blood test, immunohistochemistry analysis standardization, and PacBio and Sick Kids in Toronto are working to identify genetic variants responsible for childhood disease using HiFi WGS.
Mar 30, 2022
-
Diagnostics World News | Biology and technology have finally advanced to the point where a teentsy device for imaging the inside of the fallopian tubes is recognized both as an unmet clinical need and a plausible engineering feat. Introducing the falloposcope, intended to search for signs of early-stage ovarian cancer and currently undergoing pilot testing in volunteers having their tubes removed for reasons other than cancer to establish a baseline for normal.
Mar 29, 2022
-
Diagnostics World News | As the global COVID-19 battle wages on, the ‘silent pandemic’ of antimicrobial resistance (AMR) continues to expand around the world. As the medical community continues to evaluate new technology-based approaches to fight AMR, microbial genome sequencing coupled with artificial intelligence (AI) are among the first topics brought up for discussion, and many laboratories are already embracing these new technologies.
Mar 25, 2022
-
Diagnostic World News | Hundreds of clinical trials are underway testing therapies for treatment-resistant depression (TRD), yet until very recently there was not a clear definition of what is even being treated. But with newly proposed criteria to describe the condition, researchers and regulatory agencies have a basis for agreement that could help inform study design and potentially improve the lives of millions of people worldwide.
Mar 23, 2022
-
Diagnostics World News | Merging biotech and infotech, life science company Karius has laid the groundwork for dramatically advancing molecular diagnostics for infectious diseases on a global scale, according to Chief Medical Officer (CMO) Brad Perkins, M.D. Using technology similar to what’s being used for detecting circulating tumor DNA, the Karius “liquid biopsy” test looks for microbial cell-free DNA (cfDNA) to accurately identify more than 1,000 pathogens from a single blood draw.
Mar 18, 2022
-
Diagnostics World | In recent years, the race to develop a single test that can simultaneously screen for many cancers has heated up. Dozens of companies have thrown their hats in the ring, pursuing differing approaches to search for the very earliest signs of cancer. So where does this field currently stand? Where is it headed? And is extremely early cancer detection really possible?
Mar 16, 2022
-
Diagnostics World News | Perinatal depression is an understudied and underappreciated mood disorder, but a group of researchers in Michigan are moving the field forward with the discovery of predictive biomarkers of the condition that could one day be used for the routine screening of high-risk women. Nearly one in five new mothers experience severe depression and an estimated 14% have suicidal thoughts—and pregnancy itself, being a major inflammatory event, can be the inducer.
Mar 10, 2022
-
Diagnostics World News | Old-fashioned technology is the basis of a pioneering test that reliably predicts the spread or return of the deadliest form of skin cancer among the 20% of patients diagnosed with stage I or II melanomas that have not ulcerated. The new immunohistochemistry (IHC) test, developed by a team of scientists and clinicians at Newcastle University in the U.K., could offer relief to anxious patients as well as help shorten “ever-challenging waiting lists” for follow-up care as melanoma cases continue to rise.
Mar 8, 2022
-
Diagnostics World News | Glycosaminoglycan profiling may enable all-cancer detection, maternal RNA expression profiling can predict preterm birth, Element Biosciences enters several new collaborations, and new COVID diagnostics are available.
Mar 2, 2022
-
Diagnostics World News | During a plenary panel last week at the Molecular & Precision Med TRI-CON event, pharma and diagnostics company took on the challenges in developing companion diagnostics and how important these tests are to achieving our precision medicine aims.
Mar 1, 2022
-
Diagnostics World News | Funding for virtual drug screening, AI-enhanced microscopic pathogen identification, improved genetic variant interpretation, at-home male fertility testing, single-cell sequencing technologies, and more.
Feb 28, 2022
-
Diagnostics World News | Michael Snyder has been tracking his own health with extreme attention for 12 years now, gathering datapoints including his genomic data, blood markers, microbiome makeups, clinical measures, and much more. He’s found it extremely fruitful, and over the past two years, he’s applying what he’s learned to early diagnoses of COVID-19.
Feb 25, 2022
-
Diagnostics World News | In the opening plenary panel for the Molecular and Precision Med Tri-Con this week, Robert Green, Brigham and Women’s Hospital, led a group in exploring how genomics, digital health, and more will converge to deliver precision health. He was joined by Megan Mahoney, Stanford University; Jessica Mega, Verily Life Sciences; Sir Mark Caulfield, Barts Life Sciences & Queen Mary University of London; and Lara Jehi, Cleveland Clinic.
Feb 24, 2022
-
Diagnostics World | On the first morning of the Molecular & Precision Med Tri-Con event, Viktor Adalsteinsson, associate director of the Gerstner Center for Cancer Diagnostics at the Broad Institute, explored new tools and techniques for detecting minimal residual disease.
Feb 22, 2022
-
Diagnostics World News | Schools, airports, and other venues where large numbers of people congregate could start using a new smartphone-based diagnostic platform that rapidly and inexpensively tests for both COVID-19 and the flu from a small volume of saliva.
Feb 17, 2022
-
Diagnostics World News | Researchers in Norway have used cytokine profiling to create a baseline for what the immune system looks like in normal pregnancies as a starting point for discerning when something is going wrong—preeclampsia, for example. As it turns out, immune activity predictably modulates throughout uneventful pregnancies.
Feb 15, 2022
-
Diagnostics World News | Immunotherapies vary widely in their ability to effectively treat patients with cancer, and the reason is the differing immune states of their tumor. Only a finite number of “immune archetypes” exist across all cancers—and these distinct environments are inhabited by more than the T cells targeted by currently marketed immunotherapy drugs.
Feb 10, 2022
-
Diagnostics World | New developments in the realm of breast cancer detection continue to emerge, from recent research and partnerships newly forged to the launch of new tools and technologies.
Feb 9, 2022
-
Diagnostics World | AI-driven diagnostics for gastroenterology, live-cell super-resolution microscopy, AI-based risk stratification for breast and prostate cancer, and more.
Feb 8, 2022